GALNTL5 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:168391, GALNACT19, GALNT15, GALNTL5, GalNAc-T5L, HGNC:21725, MIM:615133, NM_145292, NP_660335, NR_033169, XM_006715862, XM_011515849, XM_011515852, XM_011515853, XM_017011793, XM_017011794, XM_017011795, XM_017011796, XP_006715925, XP_011514151, XP_011514154, XP_011514155, XP_016867282, XP_016867283, XP_016867284, XP_016867285, XR_001744572, polypeptide N-acetylgalactosaminyltransferase like 5

Omim:OMIM:615133

Id:ENSG00000106648

Hgnc:HGNC:21725

Entrez:168391

Ensembl:ENSG00000106648

Description:polypeptide N-acetylgalactosaminyltransferase like 5

Predicted to enable metal ion binding activity and transferase activity. Involved in spermatid development. Predicted to be located in late endosome membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GALNTL5's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GALNTL5.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GALNTL5.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GALNTL5.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GALNTL5.

Results found

Linked to

	Label	Description
	GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 3 V 0 CISPLATIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	Preweaning Lethality, Incomplete Penetrance (MP:0011110) Gene Set (Entity type)	A Gene Set from KOMP2
	GSE210655 3 V 2 CISPLATIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE139987 1 V 2 ROSIGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 0 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE203579 GSE203581 adenosine 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE157960 2 V 3 PROGESTERONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE157960 2 V 1 PROGESTERONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE95771 0 V 3 RUXOLITINIB MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE210655 3 V 0 CISPLATIN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

Preweaning Lethality, Incomplete Penetrance (MP:0011110)

Gene Set (Entity type)

A Gene Set from KOMP2

GSE210655 3 V 2 CISPLATIN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE139987 1 V 2 ROSIGLITAZONE MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE187006 0 V 2 VALPROIC ACID HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE203579 GSE203581 adenosine 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE157960 2 V 3 PROGESTERONE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE157960 2 V 1 PROGESTERONE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE95771 0 V 3 RUXOLITINIB MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.